— All Articles —
The latest from The Peptide Brief.
Obesity medicines compared: why the biggest weight loss is not the whole story
A landmark systematic review published in the BMJ in July 2026 compared 19 obesity medicines across 262 clinical trials. According…
3.3 Million UK Adults Expected to Use Weight Loss Jabs in 2026 — What the Numbers Really Mean
When the Pharmaceutical Journal reported this week that 3.3 million UK adults are expected to use weight loss jabs in…
Fake Wegovy Pills: How To Spot Counterfeit Weight Loss Medicine In The UK
The launch of Wegovy tablets in UK pharmacies was a significant moment for people seeking weight loss treatment. But according…
Wegovy Pill UK: Superdrug Becomes First Provider to Launch Oral Semaglutide After MHRA Approval
Superdrug launched oral semaglutide in the UK in July 2026, becoming the first provider to offer the Wegovy pill commercially…
Jeremy Clarkson Weight Loss: What UK Patients Can Actually Learn From His Mounjaro Switch
Jeremy Clarkson is not the first famous face to discuss weight loss injections publicly. But as one of Britain’s most…
Are Retatrutide Warnings Helping Patients Or Causing Fear?
In June 2026, a wave of Daily Mail warnings about unlicensed retatrutide triggered an unusually fierce public debate. Readers pushed…
UK obesity medicine demand is outpacing NHS capacity, experts warn
Demand for obesity medicines in the UK has reached a tipping point. According to Reuters, millions of Britons are actively…
Millions Using Weight Loss Drugs But UK Access Remains a Postcode Lottery, Major Survey Finds
A major new survey from the Food Foundation, published in June 2026, has found that millions of UK adults have…
Eli Lilly Weight Loss Pill Set for UK Launch by Early 2027
Eli Lilly, the American pharmaceutical giant behind Mounjaro, has confirmed it intends to launch its oral weight loss pill in…